Dr. Brunstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10201 Carnegie Ave
CA-60
Cleveland, OH 44195- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1998 - 2002
- Federal University of Rio Grande do Sul School of MedicineClass of 1990
Certifications & Licensure
- OH State Medical License 2022 - 2026
- MN State Medical License 2002 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer Start of enrollment: 2001 Apr 01
- Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant Start of enrollment: 2005 Jun 01
- Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases Start of enrollment: 2005 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study.Theodros Mamo, Darin Sumstad, Todd E DeFor, Qing Cao, Margaret L MacMillan, Claudio Brunstein, Mark Juckett, David H McKenna> ;Transplantation and Cellular Therapy. 2023 Oct 1
- Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.Betty K Hamilton, Lisa A Rybicki, Hong Li, Taylor Lucas, Donna Corrigan, Matt Kalaycio, Ronald Sobecks, Rabi Hanna, Seth J Rotz, Robert M Dean, Aaron T Gerds, Deepa Ja...> ;Blood Advances. 2023 Aug 22
- 5 citationsMulticenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.Rezvani, A. R., Chenyu Lin, Aurelie Schwarzbach, Jaime Sanz, Pau Montesinos, Patrick Stiff, Suhag Parikh, Claudio Brunstein, Corey Cutler, Caroline A Lindemans, Rabi H...> ;Transplantation and Cellular Therapy. 2023 May 1
- Join now to see all
Journal Articles
- Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source, Conditioning Regiment Toxicity, and Engraftment KineticsErhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel J Weisdorf, Nelli Bejanyan, Claudio G Brunstein, Celalettin Ustun, Aleksandr Lazaryan, Ver..., Haematologica
Abstracts/Posters
- Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Validation of Minnesota Acute Gvhd Risk Score and Identification of New Factors Associated with Initial Response to Steroids: Not All Gvhd Is Created Equal2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- University of Minnesota Opens First-Ever U.S. Clinical Trial of Engineered iPSC-Derived Cell Therapy for Blood CancerOctober 23rd, 2019
- First-Ever US Clinical Trial of Engineered iPSC-Derived Cell Therapy for Blood CancerOctober 21st, 2019
- Half-Matched Transplants Widen Pool of Donors for Leukemia and LymphomaJuly 8th, 2011
Hospital Affiliations
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
- M Health Fairview Lakes Medical CenterWyoming, Minnesota
- Cleveland ClinicCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: